Transcat (NASDAQ: TRNS) insider transactions
In the twelve months to 10 November 2026, executives and directors of Transcat reported 2 open-market sales of 7,816 shares ($673,399) and 2 open-market purchases of 3,325 shares ($329,035), by 4 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 5 November 2026 | Barbato Thomas L | Sr. VP Finance & CFO | Option exercise | +6,000 | $90.92 | 10,656 | Form 4 |
| 5 November 2026 | Barbato Thomas L | Sr. VP Finance & CFO | Shares withheld for tax | −5,488 | $108.13 | 5,168 | Form 4 |
| 5 November 2026 | Conroy Theresa A. | Chief Human Resources Officer | Option exercise | +2,000 | $63.17 | 4,364 | Form 4 |
| 5 November 2026 | Conroy Theresa A. | Chief Human Resources Officer | Shares withheld for tax | −1,550 | $108.13 | 2,814 | Form 4 |
| 5 November 2026 | Irick Jaime A | President and CEO | Open-market purchase | +2,275 | $101.26 | 2,275 | Form 4 |
| 10 September 2026 | Cairns Craig D. | Director | Option exercise | +1,587 | — | 6,590 | Form 4 |
| 10 September 2026 | DePerrior Dawn | Director | Option exercise | +1,587 | — | 2,291 | Form 4 |
| 10 September 2026 | Dominach Oksana S. | Director | Option exercise | +1,587 | — | 5,933 | Form 4 |
| 10 September 2026 | Gillette Christopher P. | Director | Option exercise | +1,587 | — | 1,787 | Form 4 |
| 10 September 2026 | Haseley Gary J. | Director | Option exercise | +1,587 | — | 40,689 | Form 4 |
| 10 September 2026 | Kaniki Mbago M. | Director | Option exercise | +1,587 | — | 4,180 | Form 4 |
| 10 September 2026 | Langston Cynthia | Director | Option exercise | +1,587 | — | 3,424 | Form 4 |
| 10 September 2026 | Mecca Robert | Director | Option exercise | +1,587 | — | 2,291 | Form 4 |
| 2 September 2026 | Dominach Oksana S. | Director | Open-market sale | −7,312 | $85.60 | 4,346 | Form 4 |
| 13 August 2026 | Dominach Oksana S. | Director | Option exercise | +10,000 | $26.27 | 14,346 | Form 4 |
| 13 August 2026 | Dominach Oksana S. | Director | Shares withheld for tax | −2,688 | $97.76 | 11,658 | Form 4 |
| 7 August 2026 | Gillette Christopher P. | Director | Open-market sale | −504 | $94.23 | 200 | Form 4 |
| 6 August 2026 | Cairns Craig D. | Director | Open-market purchase | +1,050 | $93.97 | 1,480 | Form 4 |
| 27 May 2026 | Barbato Thomas L | Sr. VP Finance & CFO | Grant or award | +1,719 | — | 5,409 | Form 4 |
| 27 May 2026 | Barbato Thomas L | Sr. VP Finance & CFO | Shares withheld for tax | −760 | $76.45 | 4,649 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Transcat page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.